Research & Educational Use Only. This protocol guide is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before beginning any research protocol.
Growth Hormone Blend Weekly Protocol Guide
⚠ No validated human dose. This compound is not FDA-approved and has no peer-reviewed human dose-finding trials. The figures below are research conventions extrapolated from preclinical (animal/in‐vitro) and community sources — not validated clinical dosing. Treat them as study references only. Research use only; not medical advice.
CJC-1295 (GHRH analog) combined with Ipamorelin (GH secretagogue) provides synergistic growth hormone release through complementary pathways.
Protocol Overview
Compound CJC-1295 / Ipamorelin (CJC-1295 (no DAC) 5mg + Ipamorelin 5mg) Category Growth Hormone Blend Vial Size 10mg total (10,000mcg) Reconstitution 2mL bacteriostatic water (5mg/mL) Route Subcutaneous injection Frequency 2–3x daily, 5 days/week
Reconstitution Instructions
Using 2mL of bacteriostatic water results in a concentration of 5mg/mL total blend. Always use sterile techniques.
Materials Needed
10mg total CJC-1295 / Ipamorelin vial (lyophilized powder) 2mL bacteriostatic water (sterile, preserved with 0.9% benzyl alcohol) Sterile syringe and needle (18-22 gauge for drawing) Alcohol swabs Clean workspace
Step-by-Step Process
Preparation: Allow the CJC-1295 / Ipamorelin vial and bacteriostatic water to reach room temperature. Wipe the rubber stoppers of both vials with an alcohol swab. Draw the Water: Using a sterile syringe, draw up exactly 2mL of bacteriostatic water. Expel any air bubbles. Inject into Vial: Insert the needle through the rubber stopper at a slight angle, aiming toward the glass wall. Slowly inject the water down the side of the vial to avoid foaming. Mix Gently: Remove the needle. Gently swirl or roll the vial between your hands. Do not shake vigorously. Check for Clarity: The solution should be clear once fully reconstituted. Do not use if cloudy.
Weekly Dosing Reference · research convention, not a validated dose
This blend contains CJC-1295 (no DAC) + Ipamorelin in a 1:1 ratio. The standard protocol uses 300–500mcg of total blend per injection, 2–3 times daily on an empty stomach. The bedtime dose is most important.
Protocol Per Injection Frequency Daily Total Weekly (5 days) Standard 300mcg blend (6 units) 3x daily (AM, post-workout, before bed) 900mcg 4,500mcg Moderate 300mcg blend (6 units) 2x daily (AM, before bed) 600mcg 3,000mcg Beginner 300mcg blend (6 units) 1x daily (before bed) 300mcg 1,500mcg
Standard dose: 300–500mcg blend per injection, 2–3x daily on empty stomach • Vial Duration: ~11–33 days depending on protocol (10mg vial)
Quick Dosing Reference (at 5mg/mL blend)
Units (Ticks) Total Blend (mcg) ~CJC-1295 ~Ipamorelin 4 200 100mcg 100mcg 6 300 150mcg 150mcg 8 400 200mcg 200mcg 10 500 250mcg 250mcg 20 1,000 500mcg 500mcg
Administration Guidelines
Administer subcutaneously before bed on an empty stomach Rotate injection sites between abdomen, thigh, and upper arm Store reconstituted peptide refrigerated at 36-46F (2-8C) Use reconstituted solution within 30 days Never freeze reconstituted peptides Document administration times and observations
Storage Requirements
State Storage Conditions Lyophilized (powder) Room temperature or refrigerated, protect from light Reconstituted Refrigerated 36-46F (2-8C), use within 30 days
⚠ Before any use: human safety data is limited or absent for many of these compounds. Consult a licensed healthcare provider first — especially if you are pregnant or nursing, have a medical condition, or take other medications.